Genetic susceptibility to aminoglycoside ototoxicity: How many are at risk?
- 1 September 2002
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 4 (5), 336-345
- https://doi.org/10.1097/00125817-200209000-00004
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- U.S. Newborn Screening Policy Dilemmas for the Twenty-First CenturyMolecular Genetics and Metabolism, 2001
- Prevalence of mitochondrial gene mutations among hearing impaired patientsJournal of Medical Genetics, 2000
- The A1555G Mutation in the 12S rRNA Gene of Human mtDNA: Recurrent Origins and Founder Events in Families Affected by Sensorineural DeafnessAmerican Journal of Human Genetics, 1999
- The Emerging Tree of West Eurasian mtDNAs: A Synthesis of Control-Region Sequences and RFLPsAmerican Journal of Human Genetics, 1999
- Maternally Inherited Cardiomyopathy: An Atypical Presentation of the mtDNA 12S rRNA Gene A1555G MutationAmerican Journal of Human Genetics, 1999
- Familial Progressive Sensorineural Deafness Is Mainly Due to the mtDNA A1555G Mutation and Is Enhanced by Treatment with AminoglycosidesAmerican Journal of Human Genetics, 1998
- Familial streptomycin ototoxicity in a South African family: a mitochondrial disorder.Journal of Medical Genetics, 1997
- Susceptibility mutations in the mitochondrial small ribosomal RNA gene in aminoglycoside induced deafnessPharmacogenetics, 1995
- Mitochondrial ribosomal RNA mutation associated with both antibiotic–induced and non–syndromic deafnessNature Genetics, 1993
- Mitochondrial DNA and human evolutionNature, 1987